Atovaquon Glenmark

Atovaquone Glenmark is an oral medication used to treat certain parasitic infections. This antimalarial drug is effective in managing conditions like Pneumocystis pneumonia.

Atovaquone Glenmark is primarily used to treat and prevent Pneumocystis pneumonia, a type of lung infection. It is also effective against malaria caused by Plasmodium falciparum. This medication is often prescribed for individuals who are at risk of these infections due to weakened immune systems.

Common effects of Atovaquone Glenmark may include nausea, vomiting, diarrhea, and stomach pain. Some users might experience headache, dizziness, or rash. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Atovaquone Glenmark should be used with caution in individuals with liver or kidney problems. It is important to follow the prescribed dosage and complete the full course of treatment. Avoid taking this medication if you are allergic to atovaquone or any of its components.

Atovaquone Glenmark may interact with certain medications, including antacids, metoclopramide, and drugs that affect liver enzymes. Alcohol consumption should be avoided as it may reduce the effectiveness of the medication. Always inform your healthcare provider about all medications you are taking.